Company Overview and News

2
Brazil’s Offshore Boom Is Facing The Same Problem As U.S. Shale

2h oilprice
Ron Patterson is a retired computer engineer. He worked in Saudi Arabia for five years, two years at the Ghazlan Power Plant near Ras Tanura…
BHI

2
Oilfield Service Companies Bet On Full Recovery

2h oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
BHI

2
US Rig Count Reaches Highest Level in Two-and-a-Half Years

2018-10-19 rigzone
U.S. drillers added four rigs this week, bringing the nation’s oil rig count to 873 – an increase of 137 oil rigs from one year ago – according to weekly data compiled by Baker Hughes, a GE Company.
BHI

17
UPDATE 8-Oil up but posts weekly loss on stock build, trade tensions

2018-10-19 reuters
NEW YORK (Reuters) - Oil prices rose on Friday on signs of surging demand in China, the world’s No. 2 oil consumer, although prices were headed for a second weekly decline on swelling U.S. inventories and concern that trade wars were curbing economic activity.
BHI GEC GE GNE

2
US Oil Rig Count Increases by 4, Prices Give Back Some of Their Daily Gain

2018-10-19 247wallst
In the week ending October 19, 2018, the number of land rigs drilling for oil in the United States totaled 873, an increase of four compared to the previous week and up by 137 compared with a total of 736 a year ago. Including 194 other land rigs drilling for natural gas, there are a total of 1,067 working rigs in the country, up week over week by four and 154 more year over year. The data come from the latest Baker Hughes North American Rotary Rig Count released on Friday afternoon.
BHI

17
U.S. rig count rises to highest since March 2015 -Baker Hughes

2018-10-19 reuters
Oct 19 (Reuters) - U.S. drillers added oil rigs for a second week in a row this week, raising the rig count to the highest level since March 2015.
BHI GEC GE GNE

2
Rig Count Rises Amid Oil Price Recovery

2018-10-19 oilprice
Julianne Geiger is a veteran editor, writer and researcher for US-based Divergente LLC consulting firm, and a member of the Creative Professionals Networking Group.
BHI

2
Parker Announces Retirement of Chief Information Officer William G. Eline, Appoints Dinu J. Parel as Successor

2018-10-19 globenewswire
CLEVELAND, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that William G. Eline, Vice President - Chief Information Officer, will retire after 40 years of dedicated service. The company has appointed Dinu J. Parel to succeed Mr. Eline in November 2018.
BHI DOV.WI PH DOV

2
Futures Movers: Oil climbs, but set for weekly loss on supply rise

2018-10-19 marketwatch
Oil futures rose Friday, with the global benchmark pushing back above $80 a barrel, but remained on track for a weekly stumble as rising U.S. inventories overshadowed concerns about U.S.-Saudi tensions.
BHI

5
Brazil Reserves And Production Update, H1 2018

2018-10-19 seekingalpha
Brazil and Petrobras (NYSE:PBR) show something in common with US LTO: even with a lot of debt and desire, and a strong resource base, it is difficult to raise production in the face of high decline rates. It may also be a lesson for the world as oil prices rise and activity picks up; it is by far the most active conventional oil region with many major projects at various stages of completion, but facing delays and schedule crowding so oil production has continued a slow decline, contrary to expectations from last year.
BHI XOM PBR

3
Big Oil's Hired Hands Chase Foreign Boom

2018-10-18 rigzone
(Bloomberg) -- The biggest providers of oilfield services are surfing a wave of international spending on the back of higher prices, but the good news is tempered by an activity slowdown in their own back yard.
BCS BHI 83SF 83SK MS 47MC

4
MLP Monthly Report: September 2018

2018-10-15 seekingalpha
The September MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
KAAC APA SNSR AND LIT BFIT GXG SIL KRMA GXF CHII EV ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI LNGR COPX QQQC GURU FANG

23
Baker Hughes Earnings Preview

2018-10-15 seekingalpha
The subsea sector is showing signs of life. It could help BHGE offset any falloff in North America land drilling.
BHI SLB GEC GE BHGE GNE SLB

2
Rethinking It

2018-10-15 seekingalpha
Risk sentiment stabilised primarily on the back of reports that the Treasury Department will not recommend China be labelled a currency manipulator, along with headlines that Trump and Xi will meet on trade seem to be enough reason for the equity sell-off to cool. But indeed never has so much been riding on the contributions of so few.
BHI

2
US Oil Rig Count Jumps by 8, Largest Increase Since Early August

2018-10-13 247wallst
In the week ending October 12, 2018, the number of land rigs drilling for oil in the United States totaled 869, an increase of eight compared to the previous week and up by 126 compared with a total of 743 a year ago. Including 193 other land rigs drilling for natural gas and one listed as miscellaneous, there are a total of 1,063 working rigs in the country, up by 11 week over week and up by 116 year over year.
BHI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to BHI / Baker Hughes Inc. on message board site Silicon Investor.

Baker Hughes Baker Hughes Baker Hughes Webhire (HIRE) - Enters the Softbank Web Webhire (HIRE) - Enters the Softbank Web Webhire (HIRE) - Enters the Softbank Web
BHIT (online auction site) BHIT (online auction site) BHIT (online auction site) BHI BHI BHI
CUSIP: 057224107